ORAGENICS INC 8-K

What Happened

• Oragenics Inc. (OGEN) filed an 8‑K (July 6, 2026) reporting the appointment of John Spencer as Chief Financial Officer, effective July 1, 2026. The company entered into an Executive Employment Agreement with Mr. Spencer providing base compensation of $200,000 and customary confidentiality, non‑competition and non‑solicitation terms (see Exhibit 10.1).
• In connection with his appointment, Mr. Spencer received an option award valued at $25,000, with an exercise price equal to the NYSE American closing price immediately prior to the grant. Mr. Spencer (age 32) joined Oragenics in April 2025 as Senior Controller, is a Florida CPA, and holds a Master of Accountancy and B.S. in Accounting from the University of South Florida.
• At the company’s Annual Meeting on June 29, 2026, shareholders re‑elected six directors (Charles Pope, Frederick Telling, Alan Dunton, Robert Koski, John Gandolfo, Natasha Giordano) and voted on several proposals, including a non‑binding advisory vote on executive compensation, authorization for a potential reverse stock split, and ratification of Cherry Bekaert LLP as independent auditors.

Key Details

• CFO appointment effective July 1, 2026; base salary $200,000 and standard restrictive covenants.
• Option award to Mr. Spencer: $25,000 value; exercise price = NYSE American closing price immediately before grant.
• Reverse stock split authorization (ratio range 1:2 to 1:50) approved by shareholders: FOR 1,239,961 / AGAINST 836,159 / ABSTAIN 27,366.
• Auditor ratification: Cherry Bekaert LLP approved as independent auditors for 2026 — FOR 1,887,381 / AGAINST 184,883 / ABSTAIN 31,225.
• Advisory (non‑binding) vote on executive compensation: FOR 806,898 / AGAINST 478,522 / ABSTAIN 24,545 (with 793,522 broker non‑votes on some proposals).

Why It Matters

• Leadership and continuity: Promoting an internal finance leader to CFO signals continuity in Oragenics’ finance and SEC reporting functions; the package (salary + options) aligns Mr. Spencer’s incentives with shareholder value without unusually large cash outlay.
• Corporate flexibility on shares: Shareholder authorization for a reverse split (1:2 to 1:50) gives the Board the option to consolidate shares within one year, which could be used to meet listing requirements or change the per‑share price — the split has not been implemented, only authorized.
• Governance signals: Re‑election of the full slate of directors and ratification of auditors maintain existing governance; the mixed but majority support in the advisory pay vote provides management with non‑binding approval of its compensation approach but shows notable dissent to monitor.